Big Developments In Cancer Research - KAUZ-TV: Newschannel 6 Now | Wichita Falls, TX

Big Developments In Cancer Research

Dr. Praveen Reddy with Texas Oncology, came on Newschannel 6 at Noon to share some of the big announcements from this year's American Society of Clinical Oncology meeting:

PROSTATE CANCER:

  • Men with advanced prostate cancer are benefiting from a new medication called Zytiga. Through clinical trials, it was discovered that a third of men with advanced prostate cancer who received the drug coupled with hormone therapy prior to surgery had only a little or no cancer at all after six months of treatment. This is very significant since most men with advanced prostate cancer have a poor prognosis due to the cancer metastasizing.
  • Click here for more information.

 

  • Additionally, it was discovered that men with minimally-spread hormone-sensitive prostate cancer benefit from continuous hormone therapy rather than intermittent hormone therapy, which was the typical treatment for prostate cancer because it was believed that it would help reduce side effects such as loss of sexual desire, weight gain, impotence, and hot flashes. However, the new study shows that men who received continuous hormone lived about two years longer than those who received intermittent hormone therapy.
  • Click here for more information.

LUNG CANCER:

  • Another big breakthrough presented at ASCO this year was the targeted therapy drug afatinib. A study showed that the drug was better than chemotherapy at keeping advanced non-small cell lung cancer (NSCLC) with mutations (changes) to the epidermal growth factor receptor (EGFR) from progressing longer.  The research showed that it took about four months longer for the cancer to progress when patients received afatinib. The drug also helped slow the development of symptoms associated with lung cancer, such as coughing and shortness of breath. Additionally, since the drug is taken orally, there are less office visits than if they were receiving chemotherapy.
  • Click here for more information.

BREAST CANCER:

  • A new breast cancer treatment dubbed the ‘smart bomb' improves the time that women with very advanced breast cancer live without the disease progressing. The treatment delivers a toxic load of chemotherapy to cancerous cells by binding it with Herceptin, the first gene-targeted therapy for breast cancer. The treatment is referred to as T-DM1 and causes fewer side effects. Women who underwent this treatment didn't experience hair loss or nausea, and the surrounding healthy tissue was left unaffected.  
  • Click here for more information.  

THE FUTURE FOR CANCER TREATMENT:  

  • Cancer treatment is getting more targeted, and we are able to test and target specific genetic mutations and attack cancerous cells without sacrificing the health of healthy tissue and cells. This will result in more effective treatment and lessen the side effects of cancer treatment overall.

 

  • News HeadlinesNewsMore>>

  • Remembering Vinita Trevino

    Remembering Vinita Trevino

    Friday, March 24 2017 7:51 PM EDT2017-03-24 23:51:54 GMT
    Vinita TrevinoVinita Trevino

    Radiant. Vibrant. Smiling. These are all words that Vinita Trevino's friends said described her. Last weekend the Petrolia native was tragically killed in a car wreck in Haskell County.

    Radiant. Vibrant. Smiling. These are all words that Vinita Trevino's friends said described her. Last weekend the Petrolia native was tragically killed in a car wreck in Haskell County.

  • 3 injured in shooting in France, reports say

    3 injured in shooting in France, reports say

    Friday, March 24 2017 7:10 PM EDT2017-03-24 23:10:21 GMT
    Friday, March 24 2017 7:10 PM EDT2017-03-24 23:10:21 GMT

    Early reports suggest a shooting in France is crime or gang-related. 

    Early reports suggest a shooting in France is crime or gang-related. 

  • Local organizations worried about tuition increase

    Local organizations worried about tuition increase

    Friday, March 24 2017 6:56 PM EDT2017-03-24 22:56:23 GMT

    In the last 15 years, college tuition at Texas Universities has jumped nearly 150%. One thing that’s not jumping is an increase in financial aid. Tiffany Uke is a senior at Midwestern State University, but since she changed her major she has another year and a half left. Uke receives financial aid for college, but with college becoming more expensive and that financial helping cover less and less, that could cause a problem. “There is this push for education and being ...

    In the last 15 years, college tuition at Texas Universities has jumped nearly 150%. One thing that’s not jumping is an increase in financial aid. Tiffany Uke is a senior at Midwestern State University, but since she changed her major she has another year and a half left. Uke receives financial aid for college, but with college becoming more expensive and that financial helping cover less and less, that could cause a problem. “There is this push for education and being ...

Powered by Frankly